People: China Regenerative Medicine International Ltd (8158.HK)
26 Jun 2019
Mr. Wang Xuejun is Chief Executive Officer, Executive Director of the Company. is a master of business administration from Nankai University. He was an executive deputy general manager of Vcanbio Cell & Gene Engineering Corp., Ltd. (stock code on the Shanghai Stock Exchange: SH600645), general manager of marketing center of Union Stemcell & Gene Engineering Co., Ltd and head of its subsidiary, and a director and general manager of certain subsidiaries of Heze Biotech Co., Ltd. He was also a director and general manager of Heze Biotech Co., Ltd. and a doctor at Tianjin Rehabilitation Center.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|